Agency Information Collection Activities: Proposed Collection; Comment Request
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
On Wednesday, October 5, 2022, the Centers for Medicare & Medicaid Services (CMS) published a notice document entitled, "Agency Information Collection Activities: Proposed Collection; Comment Request". That notice invited public comments on two separate information collection requests, under Document Identifiers: CMS-10260 and CMS-10142. Through the publication of this document, we are withdrawing the portion of the notice requesting public comment on the information collection request titled, " Medicare Advantage and Prescription Drug Program: Final Marketing Provisions." Form number: CMS-10260 (OMB control number: 0938-1051).
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 203 (Friday, October 21, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 203 (Friday, October 21, 2022)]
[Notices]
[Page 64052]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-22844]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10260]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice; partial withdrawal.
-----------------------------------------------------------------------
SUMMARY: On Wednesday, October 5, 2022, the Centers for Medicare &
Medicaid Services (CMS) published a notice document entitled, ``Agency
Information Collection Activities: Proposed Collection; Comment
Request''. That notice invited public comments on two separate
information collection requests, under Document Identifiers: CMS-10260
and CMS-10142. Through the publication of this document, we are
withdrawing the portion of the notice requesting public comment on the
information collection request titled, '' Medicare Advantage and
Prescription Drug Program: Final Marketing Provisions.'' Form number:
CMS-10260 (OMB control number: 0938-1051).
DATES: The original comment period for the document that published on
October 5, 2022, remains in effect and ends December 5, 2022.
SUPPLEMENTARY INFORMATION: In FR document, 2022-21657, published on
October 5, 2022 (87 FR 60403), we are withdrawing item 1 ``Medicare
Advantage and Prescription Drug Program: Final Marketing Provisions in
42 CFR 422.111(a)(3) and 423.128(a)(3)'' which begins on page 60404.
The notice will be republished at a later date, thereby allowing the
public to have a full 60-day comment period.
Dated: October 17, 2022.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2022-22844 Filed 10-20-22; 8:45 am]
BILLING CODE 4120-01-P
</pre></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.